+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ocular Inflammation Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017-2026

  • ID: 4851244
  • Report
  • March 2018
  • Region: Global
  • 170 pages
  • Transparency Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

Ocular Inflammation Treatment: Global Market Overview

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration. The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.  

This report offers key insights on how the global ocular inflammation treatment market will expand during the forecast period, 2017-2026. This report sheds qualitative information and forecasted market size evaluations on the global ocular inflammation treatment market expansion for the assessment period.  

Key Offerings of the Report

There are a range of advantages of availing This study, particularly for companies interested in expanding their stakes in the global ocular inflammation treatment market. A constant dialogue industry leaders, opinion makers, trade analysts and market participants has generated volumes of data, which has been analyzed across multiple parameters during the development of this study.

An all-embracive research methodology employed for developing accurate forecast on the global ocular inflammation treatment market offers insights in terms of:

  • changing stance of the FDA on uveitis drugs
  • causative factors triggering the incidence of eye inflammations across the globe
  • initiatives of governments in promoting awareness through uveitis programs
  • contribution of medical research organizations towards developing new therapies that extend the use of ocular inflammation drugs
  • addressing the instances that cite ineffectiveness of particular ocular inflammation treatments

From pricing and cost structure to supply chain characteristics, the report supplying objective information on how the global ocular inflammation treatment market will evolve in the coming years. This information has been validated through authentic quality checks and data screening processes. New opportunities for market growth have been revealed, and a slew of first-hand information makes this report a valuable document for companies aiming to expand their business in the ocular inflammation treatment market.

Global Ocular Inflammation Treatment Market: Segmental Breakdown

Region

Treatment Type

Disease Type

Mode of Administration

Distribution Channel

North America

Corticosteroids

Anterior Uveitis

Topical

Hospital Pharmacies

Latin America

Antibiotics

Posterior Uveitis

Injectable

Retail Pharmacies

Europe

Monoclonal Antibodies

Pan uveitis

Oral

Online Pharmacies

Japan

Immunosuppressant

Intermediate Uveitis

Others

Drug Stores

APEJ

Cycloplegic Agents

Episcleritis/Scleritis

MEA

Antivirals

Antifungal

Analgesics

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Assessing Details on Key Market Stakeholders

The presence of pharmaceutical industry leaders is fairly consolidated in the global market for ocular inflammation treatments. The report has profiled these market players extensively, tracking their growth till data and tracing their strategic developments in the recent past. Unbiased analysis of such information has generated insights on how a particular pharmaceutical company will take steps towards expanding its stake in the local as well as global ocular inflammation treatment markets.

The current stance of the FDA towards clearing the uveitis pipelines has also been addressed while measuring the potential of companies in contributing immensely towards the future of global ocular inflammation treatment market. Information on their investments portfolio, R&D undertakings and mergers & acquisitions has been summarized to extend the understanding of companies in terms of competitor analysis. The overall scope of this report is to ensure that key companies in the global ocular inflammation treatment market take informed steps towards future market direction.

Note: Product cover images may vary from those shown
2 of 2
1. Global Economic Outlook

2. Global Ocular Inflammation Treatment Market - Executive Summary

3. Global Ocular Inflammation Treatment Market Overview
3.1. Introduction
3.1.1. Global Ocular Inflammation Treatment Market Taxonomy
3.1.2. Global Ocular Inflammation Treatment Market Definition
3.2. Global Ocular Inflammation Treatment Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Ocular Inflammation Treatment Market Y-o-Y Growth
3.3. Global Ocular Inflammation Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Wheel of Fortune
3.7. Forecast Scenario
3.8. Average Pricing Analysis
3.9. Porter's Five Forces Analysis
3.10. Forecast Factors
3.11. PEST Analysis
3.12. Uveitis Epidemiology
3.12.1. North America Uveitis Epidemiology
3.12.2. Europe Uveitis Epidemiology
3.13. Pipeline Analysis
3.14. Regulatory Scenario
3.15. Investment Feasibility Matrix
3.16. Market Positioning & Behavior Assessment
3.17. Market Competition Structure
3.18. List of Distributors
3.19. Key Participants Market Presence (Intensity Map) By Region

4. Global Ocular Inflammation Treatment Market Analysis and Forecast 2012-2026
4.1. Global Ocular Inflammation Treatment Market Size and Forecast By Treatment Type, 2012-2026
4.1.1. Corticosteroids Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Antibiotics Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Monoclonal Antibodies Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Immunosuppressant Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Cycloplegic Agents Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Antivirals Market Size and Forecast, 2012-2026
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.1.7. Antifungal Market Size and Forecast, 2012-2026
4.1.7.1. Revenue (US$ Mn) Comparison, By Region
4.1.7.2. Market Share Comparison, By Region
4.1.7.3. Y-o-Y growth Comparison, By Region
4.1.8. Analgesics Market Size and Forecast, 2012-2026
4.1.8.1. Revenue (US$ Mn) Comparison, By Region
4.1.8.2. Market Share Comparison, By Region
4.1.8.3. Y-o-Y growth Comparison, By Region
4.2. Global Ocular Inflammation Treatment Market Size and Forecast By Disease Type, 2012-2026
4.2.1. Anterior Uveitis Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Posterior Uveitis Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Panuveitis Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Intermediate Uveitis Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.2.5. Episcleritis/Scleritis Market Size and Forecast, 2012-2026
4.2.5.1. Revenue (US$ Mn) Comparison, By Region
4.2.5.2. Market Share Comparison, By Region
4.2.5.3. Y-o-Y growth Comparison, By Region
4.3. Global Ocular Inflammation Treatment Market Size and Forecast By Mode of Administration, 2012-2026
4.3.1. Topical Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Injectables Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Oral Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Others Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
4.4. Global Ocular Inflammation Treatment Market Size and Forecast By Distribution Channel, 2012-2026
4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region
4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
4.4.3. Online Pharmacies Market Size and Forecast, 2012-2026
4.4.3.1. Revenue (US$ Mn) Comparison, By Region
4.4.3.2. Market Share Comparison, By Region
4.4.3.3. Y-o-Y growth Comparison, By Region
4.4.4. Drug Stores Market Size and Forecast, 2012-2026
4.4.4.1. Revenue (US$ Mn) Comparison, By Region
4.4.4.2. Market Share Comparison, By Region
4.4.4.3. Y-o-Y growth Comparison, By Region

5. North America Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Treatment Type
5.6. Revenue (US$ Mn) Comparison, By Disease Type
5.7. Revenue (US$ Mn) Comparison, By Mode of Administration
5.8. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Treatment Type
6.6. Revenue (US$ Mn) Comparison, By Disease Type
6.7. Revenue (US$ Mn) Comparison, By Mode of Administration
6.8. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. U.K. Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Treatment Type
7.6. Revenue (US$ Mn) Comparison, By Disease Type
7.7. Revenue (US$ Mn) Comparison, By Mode of Administration
7.8. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Japan Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Treatment Type
8.6. Revenue (US$ Mn) Comparison, By Disease Type
8.7. Revenue (US$ Mn) Comparison, By Mode of Administration
8.8. Revenue (US$ Mn) Comparison, By Distribution Channel

9. APEJ Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Malaysia Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia & New Zealand Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Treatment Type
9.6. Revenue (US$ Mn) Comparison, By Disease Type
9.7. Revenue (US$ Mn) Comparison, By Mode of Administration
9.8. Revenue (US$ Mn) Comparison, By Distribution Channel

10. MEA Ocular Inflammation Treatment Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Treatment Type
10.6. Revenue (US$ Mn) Comparison, By Disease Type
10.7. Revenue (US$ Mn) Comparison, By Mode of Administration
10.8. Revenue (US$ Mn) Comparison, By Distribution Channel

11. Global Ocular Inflammation Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Global Ocular Inflammation Treatment Market - Company Share Analysis
11.2. Global Ocular Inflammation Treatment Market - Competition Landscape
11.3. Global Ocular Inflammation Treatment Market - Company Profiles
11.3.1. Allergan Plc
11.3.2. Valeant Pharmaceuticals International, Inc.
11.3.3. Novartis AG
11.3.4. Abbvie, Inc.
11.3.5. Pfizer, Inc.
11.3.6. Cipla Ltd.
11.3.7. Akorn, Inc.
11.3.8. Eyegate Pharmaceuticals, Inc.
11.3.9. Alimera Sciences, Inc.
11.3.10. pSivida Corporation

12. Global Ocular Inflammation Treatment Market - Key Takeaways

13. Research Methodology

14. Disclaimer
Note: Product cover images may vary from those shown
Adroll
adroll